.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Dow
Moodys
US Department of Justice
Teva
Daiichi Sankyo
Cantor Fitzgerald
Healthtrust
Cipla
Federal Trade Commission

Generated: July 21, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,491,588

« Back to Dashboard

Details for Patent: 4,491,588

Title: Treatment of psoriasis and seborrheic dermatitis with imidazole antibiotics
Abstract:A method is provided for treating psoriasis and seborrheic dermatitis in humans by oral administration of an effective, lesion reducing, amount of an imidazole antibiotic.
Inventor(s): Rosenburg; E. William (Memphis, TN), Belew; Patricia W. (Germantown, TN)
Assignee: University of Tennessee Research Corporation (Knoxville, TN)
Filing Date:Mar 17, 1983
Application Number:06/474,214
Claims:1. A method of treating psoriasis or seborrheic dermatitis in humans comprising the oral administration of an effective, lesion reducing, amount of an imidazole antibiotic to said humans, said imidazole antibiotic being selected from the group consisting of ketoconazole and metronidazole.

2. The method of claim 1 wherein said imidazole antibiotic is ketoconazole.

3. The method of claim 2 wherein said antibiotic is administered in amounts of from about 200 mg. to about 400 mg. per day.

4. The method of claim 1 wherein said imidazole antibiotic is metronidazole.

5. The method of claim 4 wherein said antibiotic is administered in amounts of from about 750 mg. to about 1250 mg. per day.

6. The method of claim 1 wherein said antibiotic is administered in amounts of from about 50 mg. to about 1250 mg. per day.

7. The method of claim 1 wherein said antibiotic is administered in amounts of from about 200 mg. to about 400 mg. per day.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Fish and Richardson
Citi
McKesson
Harvard Business School
Chinese Patent Office
Accenture
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot